Rmb Capital Management, LLC Editas Medicine, Inc. Transaction History

Rmb Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$9.99 - $21.35 $594,195 - $1.27 Million	-59,479 Reduced 70.8%	24,536 $290,000
Q1 2022 May 06, 2022	SELL	$14.08 - $27.63 $863,484 - $1.69 Million	-61,327 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$26.55 - $40.57 $338,220 - $516,821	12,739 Added 26.22%	61,327 $1.63 Million
Q3 2021 Oct 20, 2021	BUY	$39.27 - $72.94 $314 - $583	8 Added 0.02%	48,588 $2 Million
Q2 2021 Aug 13, 2021	BUY	$31.29 - $56.64 $813,978 - $1.47 Million	26,014 Added 115.28%	48,580 $2.75 Million
Q1 2021 May 12, 2021	BUY	$39.71 - $90.58 $896,095 - $2.04 Million	22,566 New	22,566 $948,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.